Neogene Therapeutics is a biotech company providing cancer patients with T cell therapies targeting mutated proteins called neo-antigens.
Neogene Therapeutics has raised €93M across 1 funding round from 3 investors, most recently a round in Sep 2020. Based in Amsterdam, Netherlands; founded 2018; active in Healthtech. Acquired by AstraZeneca in 2022. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-14 | Other | €93M | EcoR1 Capital,Jeito Capital,Syncona Partners LLP | View deal → |
